Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04439825 · ClinicalTrials.gov registry record · Phase 1
Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction
A Phase 1 study of Mood, sponsored by DeNova Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04439825 is a Phase 1 study of Mood that has completed, run by DeNova Research. The registered enrollment target is 45 participants, below the 3,658-participant average among 29 other Mood trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04439825, a Phase 1 study of Mood, has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Botox treatment into the upper one third of the face (glabella, forehead lines and/or lateral canthal lines) to analyze mood and self -appearance satisfaction in a Post Covid period on non-naïve Botox patients
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Botulinum Neurotoxin
Study Locations (1)
Illinois
- DeNova Research - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-07-20 |
| Est. Completion | 2020-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04439825
The ClinicalTrials.gov registry entry for NCT04439825 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,658-participant average among 29 other Mood trials with a reported enrollment target (99% lower). The listed sponsor is DeNova Research, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mood appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04439825 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04439825 about?
NCT04439825 is a clinical study titled "Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction". Botox treatment into the upper one third of the face (glabella, forehead lines and/or lateral canthal lines) to analyze mood and self -appearance satisfaction in a Post Covid period on non-naïve Botox patients
What is the current status of trial NCT04439825?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2020-07-20. Estimated completion is 2020-12-01.
What conditions does trial NCT04439825 study?
This clinical trial studies the following conditions: Mood.
What interventions are being tested in trial NCT04439825?
The interventions under investigation include: Placebo (DRUG), Botulinum Neurotoxin (DRUG).
Who is sponsoring clinical trial NCT04439825?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04439825 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Research Framework Exploring Sleep Health
RECRUITING
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Developing Resilience and Anxiety Management Through the Arts
RECRUITING · NA
-
Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study
RECRUITING
-
Contraceptive Hormone and Reward Measurement (CHARM Study)
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.